Menu
No results found.
688029
Micro-Tech (Nanjing) Co.,Ltd – SHA
Weekly Share Price & Valuation Overview
Market Overview
Open
84.3100
Close
92.3900
High
93.6900
Low
84.2700
Trend
0.72949
Micro-Tech (Nanjing) Co.,Ltd
China
• SHA - Shanghai Stock Exchange
• 688029
• Currency: CNY
Micro-Tech (Nanjing) Co.,Ltd researches, develops, manufactures, and sells minimally invasive medical devices to hospitals and clinics worldwide. It offers micro-tech endoscopy gastroenterology devices, such as biliary (longwire), biliary (shortwire), biopsy, dilation and hemostasis products, EUS, nitinol stents, resection products, retrieval devices, and accessories; and pulmonology products, such as airway stents, biopsy, dilation balloons, retrieval devices, and accessories. The company also offers OEM/ODM services. Micro-Tech (Nanjing) Co.,Ltd was founded in 1999 and is based in Nanjing, China.
Key strengths
- Growth + profitability: double-digit revenue and profit margins.
- Healthy operating margin (≥15%) indicates efficient core operations.
- High gross margin (≥35%) suggests strong pricing power or cost control.
- Double-digit profit margin (≥10%) supports robust bottom-line economics.
- ROE ≥15% reflects strong returns on shareholder equity.
- ROA ≥7% shows efficient use of assets.
- Revenue growth ≥10% indicates solid top-line momentum.
- Earnings growth ≥10% supports improving profitability trajectory.
- Quick ratio ≥1.0 indicates obligations can be met without inventory.
- Net cash balance sheet provides flexibility for downturns and investment.
Scale & Structure
Core size and share structure. TTM values unless noted. “Estimated” where reconciled from per-share × shares.
- Market Cap Total equity value of the company (share price × shares outstanding).
- CNY 18.39B
- Enterprise Value Operating value: market cap + total debt − cash.
- CNY 16.50B
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- CNY 2.99B
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- CNY 1.93B
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- CNY 692.57M
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- CNY 15.92
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- 3.23
- Dividend Yield Annual dividend ÷ share price. Reconciled using dividend per share when available.
- 1.53%
- Shares Outstanding
- 187.85M
- Float Shares
- 83.21M
- Implied Shares Outstanding
- 187.85M
Profitability & Efficiency
TTM basis. “Reconciled” = numerator ÷ TTM revenue. Margins reflect latest TTM calculations.
- Operating Margin (TTM) Strong Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
23.06%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
23.19%
- Gross Margin (TTM) Reconciled Strong Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
64.75%
- Profit Margin (TTM) Solid Net income ÷ revenue over the last twelve months (reconciled when possible).
-
20.29%
- ROA Strong Return on assets: net income ÷ total assets.
-
8.18%
- ROE Excellent Return on equity: net income ÷ shareholder equity.
-
15.78%
Growth
Growth rates are YoY unless labeled QoQ.
- Revenue Growth Strong Year-over-year revenue growth.
-
21.40%
- Earnings Growth (YoY) Strong Year-over-year earnings growth.
-
19.80%
- Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-
21.20%
Liquidity & Solvency
Balance-sheet health. Debt metrics shown as latest ratios; D/E is a ratio (not %).
- Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
- 3.34
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 0.03
- Total Cash Cash and equivalents.
- CNY 2.09B
- Total Debt Short + long-term interest-bearing debt.
- CNY 116.02M
- Net Debt Net Cash Total debt − cash (negative = net cash).
- CNY -1.97B
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 0.17
Cash Flow
Shown only when internally consistent; margins are TTM.
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- CNY 641.56M
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- CNY 81.86M
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
21.48%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
2.74%
- Cash Conversion (OpCF/EBITDA)
- 0.93
Sharemaestro House View
Confidence: 2
Sharemaestro internal conviction (0–3, higher is better).
Risk: 3
Sharemaestro internal risk profile (0–3, higher is safer).
Operational: 3
Operational quality/consistency (0–3, higher is better).
Composite Score: 3
Overall internal composite (0–3, higher is better).
Suggested Allocation: 5.00%
Indicative portfolio weighting suggestion based on house view.
Structural Insights
(experimental)
Ownership & Liquidity
Free Float
Proportion of shares available for public trading.
44.3%
Insiders
Shares held by company insiders (officers, directors).
47.1%
Institutions
Shares held by institutions (funds, pensions).
17.6%
Capital Structure
Potential Dilution
Increase in share count if options/convertibles exercise.
None detected
Net Debt
Total debt − cash (negative = net cash).
CNY -1.97B
-66.1% of revenue
Net debt relative to revenue — debt load vs business scale.
Resilience Score
0–100 composite of liquidity, leverage and cash conversion; higher is better. If inputs are unavailable, we estimate using proxies (Net debt vs revenue, Cash-to-Debt). It is a guide, not a rating.
91
Methodology Notes
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
As of: 2025-08-18 10:12
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.
AI generated insights not available yet. Sign in to generate the snapshot.